Critical Path Institute’s 2026 Clinical Outcome Assessment (COA) Program Annual Meeting took place April 16–17, 2026, at the Washington Marriott at Metro Center in Washington, D.C.
This year’s meeting brought together leaders from across industry, regulatory agencies, academia, patient organizations, and technology and allied service partners to advance the science and application of COAs in medical product development. Building on the strong engagement and momentum from last year, the 2026 program featured deep-dive sessions, case studies, and multi-stakeholder discussions on pressing issues in the field, including:
- Using patient experience data to inform value assessment for access decision making
- Pulling back the curtain: Multi-stakeholder insights on electronic clinical outcome assessment implementation
- Incorporating the patient voice into clinical trial design: More than just checking the box
- From meaningful aspect of health to metric to endpoint: How multidisciplinary teams form a comprehensive approach to digitally-derived endpoints
- Revisiting meaningful change: Current thinking on establishing and applying benchmarks
- Addressing challenges in rare disease clinical trials: Methodological case studies
We will post a detailed recap, complete with session recordings, posters and presentation soon.
